Navigation Links
Combination of 2 novel anti-cancer agents may help fight CML resistant to current therapy
Date:5/29/2008

ety of Hematology, which appeared online May 27.

Further, Grant said that the interaction between these agents may occur at multiple levels, including potentiation of Bcr/Abl inhibition as well as enhanced disruption of aurora kinase and mitosis. In addition, the group demonstrated that vorinostat-mediated up-regulation of Bim, a pro-apoptotic protein, contributed significantly to the effectiveness of this regimen.

Our findings suggest it may be possible to develop a clinical regimen combining a third-generation Bcr/Abl kinase and aurora kinase inhibitor, such as MK-0457, with histone deacetylase inhibitors, such as vorinostat, Grant said.

Theoretically, this combination could improve upon the results of Bcr/Abl kinase inhibitors administered alone, particularly in the case of imatinib-resistant disease, he said. Further preclinical studies are underway to test this hypothesis.


'/>"/>

Contact: Sathy Achia Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Combination therapy reverses effects of portal hypertension in rats
3. Combination vaccines okay for infants, study shows
4. Antidepressants and painkillers - a dangerous combination
5. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Drug combination might offer hope for patients deadly brain tumors
8. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
9. Combination targets: some drugs may work best when they work together
10. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
11. Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... York, New York (PRWEB) July 30, 2014 ... from uncontrollable brain bleeding has filed a Xarelto lawsuit ... by the blood thinner, Bernstein Liebhard LLP reports. According ... Court for the District of Vermont on July 25th, ... days when he suffered an irreversible brain bleed that ...
(Date:7/30/2014)... 2014 Imprivata ® (NYSE: ... and secure communications solutions for the healthcare industry, ... the most widely selected single sign-on (SSO) solution ... electronic medical records (EMR) systems with a 51 ... percent in the last 12 months), according to ...
(Date:7/30/2014)... Visitors to our region recognize how special it ... protection. Bob Kiesendahl, one of the owners of Woodloch ... Conservancy for donations collected through participation in the Green ... fast, as visitors welcome the opportunity to invest in ... The Kiesendahl family has owned Woodloch Resort for multiple ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Hamilton ... opening of its new Carmel office on July 30th. ... will finally be moving to the state-of-the-art suite, located ... and innovative space will allow for one-on-one patient comfort, ... surgery experience. , Dr. Hamilton’s new office-suite will ...
(Date:7/30/2014)... (HealthDay News) -- Some obese people have a genetic ... in their brains when they see food, researchers report. ... triggers feelings of pleasure and gratification at the sight ... designed to prevent overeating, the scientists suggested. More ... typically caused by a combination of overeating, a ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:Imprivata Achieves 51 Percent Single Sign-on Market Share Amongst U.S. Hospitals Using McKesson Paragon or Horizon EMR Systems, According to HIMSS Analytics 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:Gene Mutation May Make Food More Tempting 2
... Health Advocate Christy Turlington Burns will speak at the ... Health meeting at the AAP National Conference & Exhibition ... ET. Ms. Turlington Burns is the founder of Every ... to increase public awareness of and support for improved ...
... developed by the Centers for Disease Control and ... Pediatrics (AAP), will be launched at the 2011 ... Oct. 15-17. "Autism Case Training -- ... on the fundamental components of identifying, diagnosing, and ...
... New research presented this week highlights the ability ... investigate publicly available genomic data to assess biological ... prospective cancer biomarkers for further validation. The unique ... not possible by other methods, from the massive ...
... onset breast tenderness after starting combination hormone therapy may ... women who don,t experience breast tenderness, a study by ... One reason for this may be that their breasts ... was much more pronounced after initiation of estrogen and ...
... Il. -- MRI scanning could become a powerful new ... according to Loyola University Health System cardiologist Binh An ... MRI study of patients who had recently begun taking ... cholesterol drugs significantly reduced the amount of cholesterol in ...
... 14 (HealthDay News) -- One in six cellphones in Britain ... coli, likely because so many people don,t wash their hands ... The findings also suggest that many people lie about their ... of Hygiene & Tropical Medicine and Queen Mary, University of ...
Cached Medicine News:Health News:CDC to launch new autism curriculum at AAP national conference & exhibition 2Health News:Drug safety, efficacy, and potential new cancer biomarker predicted by NextBio 2Health News:Drug safety, efficacy, and potential new cancer biomarker predicted by NextBio 3Health News:Breast tenderness in women getting combo hormone therapy associated with increase in breast density 2Health News:Breast tenderness in women getting combo hormone therapy associated with increase in breast density 3Health News:MRIs could become powerful tools for monitoring cholesteral therapy 2Health News:1 in 6 Cellphones in Britain Contaminated With 'Fecal Matter' 2
(Date:7/30/2014)... ALEXANDRIA, Va. , July 30, 2014 /PRNewswire-USNewswire/ ... of Managed Care Pharmacy (AMCP) last evening expressed ... developed by the Joint Commission of Pharmacy Practitioners ... other member organizations over a two-year period to ... process for pharmacists.  "Pharmacists are ...
(Date:7/30/2014)... 30, 2014 PuraMed BioScience ® , ... over-the-counter (OTC) medicinal and healthcare products, announced today ... name along with the name,s red and yellow ... trademarked name MigraPure ®  going forward. The ... homeopathic, natural migraine pain reliever will be reintroduced ...
(Date:7/30/2014)... -- Research and Markets has announced the addition of ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... a lower CAGR in developed countries; however, it is expected to ... , India , and Brazil ... of the hematology analyzers and reagents market is driven by factors ...
Breaking Medicine Technology:AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2
... 13, 3010 Amgen (Nasdaq: AMGN ) ... evaluating XGEVA™ (denosumab) versus placebo in 1,432 men with ... study, demonstrated that XGEVA significantly improved median bone metastasis-free ... p=0.03) compared to placebo (primary endpoint), and significantly improved ...
... Fla., Dec. 13, 2010 The creators of the innovative Pill ... toys and a much needed medication management system to pediatric ... at Broward General, in Fort Lauderdale, Florida. ... will be onsite Wednesday, December 15, from 1-3 pm distributing ...
Cached Medicine Technology:XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 2XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 3XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 4XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 5XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 6XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 7Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Children's Hospital of Broward General 2
Inquire...
... with low electroendosmosis (EEO) ... DNA/RNA applications. If separated ... be used as substrates ... and restriction endonucleases, a ...
... NuSieve 3:1 Agarose is a molecular biology grade, ... for fine resolution of small DNA, RNA, and ... enhance the speed of gel processing and blotting. ... resolution of DNA fragments up to 1,000 bp, ...
... With a very high gel ... exclusion limit, Certified megabase agarose is ... FIGE applications. The gels remain easy ... as 0.3% and allow shorter run ...
Medicine Products: